Company / Return on Assets (ROA)
PALVELLA THERAPEUTICS, INC. Return on Assets (ROA) History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-19.8%
FY2024
5-year range
-34.8% / 247.6%
FY2020-FY2024
Trend
-108.0%
vs FY2023
Sector context
#99 of 213
Health Care
What the data says
At -19.8%, PALVELLA THERAPEUTICS, INC.'s return on assets (roa) ranks #99 of 213 in the Health Care sector. Return on Assets (ROA) has fluctuated over the past 10 years, ranging from -65.0% in FY2016 to 247.6% in FY2023.
Based on SEC 10-K filings.
-19.8% in FY2024 with a 5-year CAGR of -1.7%.
Improved from -34.8% to -19.8% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +4.5pp
- 5-Year Change
- -1.7pp
- 10-Year Change
- -
Sector benchmark
#99 of 213 in Health CareTop 46% of 213This company -19.8% Sector average -24.2%
▼
+18.2% above sector average
Key checks
Key Insights
- In FY2024, return on assets (roa) decreased 108.0% year-over-year.
- Currently 4.4pp above the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2023.
- Lowest return on assets (roa) in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 1.15 (distress zone, below 1.8 threshold)
- Strong profit margin: 43.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -19.8% | -108.0% |
| FY2023 | 247.6% | +810.6% |
| FY2022 | -34.8% | -43.8% |
| FY2021 | -24.2% | +0.0% |
| FY2020 | -24.3% | -34.3% |
| FY2019 | -18.1% | -44.5% |
| FY2018 | -12.5% | +43.1% |
| FY2017 | -21.9% | +66.2% |
| FY2016 | -65.0% | -57.0% |
| FY2015 | -41.4% | +8.1% |
As of FY2024 · SEC 10-K Annual Filings · Updated Jun 30, 2026